Objectives

After participating in this educational activity, attendees should be able to:
1. Analyze diagnostic criteria and risk factors for development of Clostridium difficile (C. diff) in pediatric patients

2. Outline guideline recommendations for treatment of C. diff in pediatric patients

3. Compare efficacy of treatment options for C. diff in immunocompromised pediatric patients

4. Formulate a treatment plan for an immunocompromised pediatric patient with diagnosed C. diff

Faculty

Taylor Hodle, PharmD 
PGY1 Pharmacy Resident
Pharmacist
Baystate Medical Center 

None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.